A First-In-Human Phase 1 Study Of Oral Loxo-338, A Selective Bcl2 Inhibitor, In Patients With Advanced Hematologic Malignancies
LOXO-338
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A First-In-Human Phase 1 Study Of Oral Loxo-338, A Selective Bcl2 Inhibitor, In Patients With Advanced Hematologic Malignancies ### Output: LOXO-338